Response to the expertise: procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen.
Koch
Klaus
K
Lange
Stefan
S
D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine / Q000191:economics* / Q000592:standards; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics / Q000592:standards*; D004364:Pharmaceutical Preparations / Q000191:economics / Q000592:standards*; D011358:Product Surveillance, Postmarketing
D004364:Pharmaceutical Preparations